Clinical Trial Update: Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 trial is evaluating a BRAF-targeted therapy after surgery and standard chemotherapy in patients with BRAF-mutant colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• BRAF-targeted therapy

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING